Rezurock 200 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FG8PK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,279
Award facts
- Contract value 100% obligated
- $11,278.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rezurock 200 mg tablets in quantities of 30 units. This contract is valued at $11,278.69 with a firm fixed-price structure and carries an ultimate completion date of August 20, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio with the DLA encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This specific delivery order for Rezurock, a pharmaceutical product, reflects the company's ongoing role in supplying specialized medications to support military and federal healthcare operations through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FG8PK?
SPE2DB25FG8PK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FG8PK worth?
The government has obligated $11,279 on SPE2DB25FG8PK.
Is contract SPE2DB25FG8PK an order under another contract?
Yes. SPE2DB25FG8PK is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG8PK competed?
The extent of competition for SPE2DB25FG8PK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award